ISPC vs TT · rev $9.3M vs P/E 36, rev $21.32B
iSpecimen Inc (ISPC) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
ISPC currently screens at market cap $4.4M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the ISPC and TT stock pages for the full models.
Not investment advice.